Endocrinology
Conference Coverage
Low-calorie sweeteners may allow more glucose to enter fat cells
ORLANDO – Fat cells from people who use low-calorie sweeteners may have more glucose transporters, allowing more sugar into the cells.
Conference Coverage
Simple changes shorten door-to-insulin time for diabetic ketoacidosis
ORLANDO – A few simple adjustments in standing orders shaved 20 minutes off the time one emergency department took to deliver insulin to pediatric...
From the Journals
Study shows no adverse events with long-term denosumab in postmenopausal women
Denosumab, taken long term, is not linked with any adverse events, an analysis of the participants in the FREEDOM trial showed.
Conference Coverage
Neurokinin receptor antagonist nearly halves hot flashes
ORLANDO – The novel approach reduced hot flashes without the need for estrogen in a phase II trial.
Conference Coverage
Coverage denials plague U.S. PCSK9-inhibitor prescriptions
WASHINGTON – A prescription for a PCSK9 inhibitor isn’t likely to be covered.
Conference Coverage
Dulera inhaler linked to adrenocorticotropic suppression in small case series
ORLANDO – Why are some children with asthma short for their age? Maybe it’s their inhaler.
Conference Coverage
Death watch intensifies for HDL-based interventions
WASHINGTON – The study of HDL cholesterol–based interventions to treat atherosclerotic disease “is on life support.”
Conference Coverage
Infants’ head circumference larger with PCOS moms on metformin
Infants born to women with PCOS who took metformin during pregnancy have larger heads than those born to women who took placebo.
Conference Coverage
Most children with growth disorders benefit from growth hormone
Most children with a variety of growth disorders benefited from being treated with somatropin for at least 4 years.
Conference Coverage
BRCA2 mutations linked to greater risk for pancreatic cancer
MIAMI BEACH – A higher incidence of pancreatic abnormalities on imaging among BRCA2 mutation carriers may provide a potential screening target.
Conference Coverage
Bioidentical hormone replacement fares well in phase III trial
ORLANDO – Phase III trial results represent another step toward FDA approval of a formulation of bioidentical hormone therapy to treat hot flashes...